Exact Sciences Corp. (EXAS) concluded trading on Thursday at a closing price of $67.94, with 2.84 million shares of worth about $192.98 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.58% during that period and on September 26, 2024 the price saw a gain of about 0.25%. Currently the company’s common shares owned by public are about 184.77M shares, out of which, 181.98M shares are available for trading.
Stock saw a price change of -4.08% in past 5 days and over the past one month there was a price change of 13.44%. Year-to-date (YTD), EXAS shares are showing a performance of -8.16% which increased to 2.27% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $40.62 but also hit the highest price of $79.62 during that period. The average intraday trading volume for Exact Sciences Corp. shares is 2.72 million. The stock is currently trading 5.32% above its 20-day simple moving average (SMA20), while that difference is up 16.58% for SMA50 and it goes to 15.36% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exact Sciences Corp. (NASDAQ: EXAS) currently have 184.77M outstanding shares and institutions hold larger chunk of about 97.27% of that.
The stock has a current market capitalization of $12.55B and its 3Y-monthly beta is at 1.27. It has posted earnings per share of -$0.96 in the same period. It has Quick Ratio of 1.98 while making debt-to-equity ratio of 0.87. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EXAS, volatility over the week remained 3.55% while standing at 4.86% over the month.
Stock’s fiscal year EPS is expected to rise by 17.44% while it is estimated to increase by 115.13% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on August 28, 2024 offering an Overweight rating for the stock and assigned a target price of $75 to it. Coverage by Scotiabank stated Exact Sciences Corp. (EXAS) stock as a Sector outperform in their note to investors on June 27, 2024, suggesting a price target of $70 for the stock. On June 03, 2024, Jefferies Resumed their recommendations, while on January 02, 2024, The Benchmark Company Upgrade their ratings for the stock with a price target of $91. Stock get a Buy rating from Guggenheim on December 14, 2023.
